(NASDAQ: RDNT) Radnet's forecast annual revenue growth rate of 4.94% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 2.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 49.46%.
Radnet's revenue in 2025 is $1,869,356,000.On average, 4 Wall Street analysts forecast RDNT's revenue for 2025 to be $147,183,542,043, with the lowest RDNT revenue forecast at $146,548,787,414, and the highest RDNT revenue forecast at $147,840,055,400.
In 2026, RDNT is forecast to generate $160,086,167,875 in revenue, with the lowest revenue forecast at $158,013,386,388 and the highest revenue forecast at $163,331,519,734.